Boston Scientific (BSX) executive compensation, 2026 proxy

Michael F. Mahoney, Chairman and Chief Executive Officer, was paid $23.5M in 2025. The CEO-to-median-employee pay ratio was 348:1, on median employee pay of $67,539.

Filed
March 18, 2026
Annual meeting
April 30, 2026
Pay year
2025
Named executives
1
CEO total pay
$23.5M2025
CEO to median employee
348:1median $67,539
Prior say-on-pay support
92%of votes cast
CEO Target At-Risk Pay
92.3%Percentage of target total direct compensation.
Median Employee Pay
$67,539Annual total compensation for 2025.
CEO Pay Ratio
348:1Ratio of CEO to median employee pay.

How Mahoney was paid

$23.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Michael F. MahoneyChairman and Chief Executive Officer$23,532,050

What changed and why

  • $23.5MMichael F. Mahoney received total compensation of $23,532,050 in 2025.
  • 91.9%Stockholders approved the 2024 executive compensation program with 91.9% support at the 2025 annual meeting.
  • 92.3%Approximately 92.3% of the target value of primary compensation elements for the CEO consisted of at-risk, performance-based incentive compensation.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.